These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 39154304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A retrospective study of SPECT/CT scans using SUV measurement of the normal pelvis with Tc-99m methylene diphosphonate.
    Wang R, Duan X, Shen C, Han D, Ma J, Wu H, Xu X, Qin T, Fan Q, Zhang Z, Shi W, Guo Y.
    J Xray Sci Technol; 2018; 26(6):895-908. PubMed ID: 30103368
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate.
    Kaneta T, Ogawa M, Daisaki H, Nawata S, Yoshida K, Inoue T.
    Am J Nucl Med Mol Imaging; 2016; 6(5):262-268. PubMed ID: 27766184
    [Abstract] [Full Text] [Related]

  • 5. Quantification evaluation of 99mTc-MDP concentration in the lumbar spine with SPECT/CT: compare with bone mineral density.
    Huang K, Feng Y, Liu D, Liang W, Li L.
    Ann Nucl Med; 2020 Feb; 34(2):136-143. PubMed ID: 31768820
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative 99mTc-MDP SPECT/CT as an alternative to 18F-NaF PET/CT for objective assessment of osteoblastic bone metastases.
    Coskun N, Cagdas B, Yildirim N.
    Hell J Nucl Med; 2022 Feb; 25(2):132-137. PubMed ID: 35913859
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of CT-based SUV normalization.
    Devriese J, Beels L, Maes A, Van de Wiele C, Pottel H.
    Phys Med Biol; 2016 Sep 07; 61(17):6369-83. PubMed ID: 27498994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial.
    Zhang Y, Lin Z, Li T, Wei Y, Yu M, Ye L, Cai Y, Yang S, Zhang Y, Shi Y, Chen W.
    Sci Rep; 2022 Sep 26; 12(1):15993. PubMed ID: 36163353
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective study of Na[18F]F PET/CT for cancer staging in morbidly obese patients compared with [99mTc]Tc-MDP whole-body planar, SPECT and SPECT/CT.
    Usmani S, Ahmed N, Gnanasegaran G, Al Kandari F, Marafi F, Bani-Mustafa A, Musbah A, Jassem Almashmoum M, Van den Wyngaert T.
    Acta Oncol; 2022 Oct 26; 61(10):1230-1239. PubMed ID: 35862646
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative [99mTc]Tc-MDP SPECT/CT correlated with [18F]NaF PET/CT for bone metastases in patients with prostate cancer.
    Tanaka K, Norikane T, Mitamura K, Yamamoto Y, Maeda Y, Fujimoto K, Takami Y, Ishimura M, Arai-Okuda H, Tohi Y, Kudomi N, Sugimoto M, Nishiyama Y.
    EJNMMI Phys; 2022 Dec 05; 9(1):83. PubMed ID: 36469149
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.